Drug Approval | September 21, 2022
Tezspire approved in the EU for the treatment of severe asthma
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
Apollo Pharmacy has over 50% market share amongst India’s organized pharmacies
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
Rymti is indicated in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis
Subscribe To Our Newsletter & Stay Updated
